Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marwan Fakih

Showing results (121-130 of 200) with videos related to

Pageof 20
Sort By:
Cancer Prevention Research (Philadelphia, Pa.)|August 18, 2011
Methyl selenocysteine: single-dose pharmacokinetics in menJames R Marshall, Clement Ip, Karen Romano, et al.
European Journal of Cancer (Oxford, England : 1990)|July 22, 2025
Impact of trifluridine/tipiracil plus bevacizumab on tumor shrinkage and depth of response in refractory metastatic colorectal cancer: analysis of the SUNLIGHT trialJulien Taieb, Dominik P Modest, Marwan Fakih, et al.
Future Oncology (London, England)|July 2, 2024
Plain language summary of SUNLIGHT: trifluridine/tipiracil and bevacizumab for refractory metastatic colorectal cancerGerald W Prager, Julien Taieb, Marwan Fakih, et al.
Journal of Gastrointestinal Oncology|January 5, 2018
Pilot trial of CRLX101 in patients with advanced, chemotherapy-refractory gastroesophageal cancerJoseph Chao, James Lin, Paul Frankel, et al.
Oncotarget|November 8, 2017
A phase I clinical trial of binimetinib in combination with FOLFOX in patients with advanced metastatic colorectal cancer who failed prior standard therapyMay Cho, Jun Gong, Paul Frankel, et al.
JNCI Cancer Spectrum|May 2, 2024
A phase I/II study of nintedanib and capecitabine for refractory metastatic colorectal cancerPatrick M Boland, John M L Ebos, Kristopher Attwood, et al.
Cancer Chemotherapy and Pharmacology|August 24, 2004
Pharmacokinetic studies of 9-nitrocamptothecin on intermittent and continuous schedules of administration in patients with solid tumorsLaura L Jung, Ramesh K Ramanathan, Merrill J Egorin, et al.
Clinical Colorectal Cancer|September 30, 2019
Efficacy of PD-1 Blockade in Refractory Microsatellite-Stable Colorectal Cancer With High Tumor Mutation BurdenJun Gong, Mandy D Robertson, Edward Kim, et al.
World Journal of Gastrointestinal Surgery|July 31, 2015
Accuracy of computed tomography in nodal staging of colon cancer patientsAudrey H Choi, Rebecca A Nelson, Hans F Schoellhammer, et al.
The Oncologist|April 6, 2023
BRAF V600E/RAS Mutations and Lynch Syndrome in Patients With MSI-H/dMMR Metastatic Colorectal Cancer Treated With Immune Checkpoint InhibitorsRaphael Colle, Sara Lonardi, Marine Cachanado, et al.
Pageof 20

Showing results (121-130 of 200) with videos related to

Sort By:
Pageof 20
Cancer Prevention Research (Philadelphia, Pa.)|August 18, 2011
Methyl selenocysteine: single-dose pharmacokinetics in menJames R Marshall, Clement Ip, Karen Romano, et al.
European Journal of Cancer (Oxford, England : 1990)|July 22, 2025
Impact of trifluridine/tipiracil plus bevacizumab on tumor shrinkage and depth of response in refractory metastatic colorectal cancer: analysis of the SUNLIGHT trialJulien Taieb, Dominik P Modest, Marwan Fakih, et al.
Future Oncology (London, England)|July 2, 2024
Plain language summary of SUNLIGHT: trifluridine/tipiracil and bevacizumab for refractory metastatic colorectal cancerGerald W Prager, Julien Taieb, Marwan Fakih, et al.
Journal of Gastrointestinal Oncology|January 5, 2018
Pilot trial of CRLX101 in patients with advanced, chemotherapy-refractory gastroesophageal cancerJoseph Chao, James Lin, Paul Frankel, et al.
Oncotarget|November 8, 2017
A phase I clinical trial of binimetinib in combination with FOLFOX in patients with advanced metastatic colorectal cancer who failed prior standard therapyMay Cho, Jun Gong, Paul Frankel, et al.
JNCI Cancer Spectrum|May 2, 2024
A phase I/II study of nintedanib and capecitabine for refractory metastatic colorectal cancerPatrick M Boland, John M L Ebos, Kristopher Attwood, et al.
Cancer Chemotherapy and Pharmacology|August 24, 2004
Pharmacokinetic studies of 9-nitrocamptothecin on intermittent and continuous schedules of administration in patients with solid tumorsLaura L Jung, Ramesh K Ramanathan, Merrill J Egorin, et al.
Clinical Colorectal Cancer|September 30, 2019
Efficacy of PD-1 Blockade in Refractory Microsatellite-Stable Colorectal Cancer With High Tumor Mutation BurdenJun Gong, Mandy D Robertson, Edward Kim, et al.
World Journal of Gastrointestinal Surgery|July 31, 2015
Accuracy of computed tomography in nodal staging of colon cancer patientsAudrey H Choi, Rebecca A Nelson, Hans F Schoellhammer, et al.
The Oncologist|April 6, 2023
BRAF V600E/RAS Mutations and Lynch Syndrome in Patients With MSI-H/dMMR Metastatic Colorectal Cancer Treated With Immune Checkpoint InhibitorsRaphael Colle, Sara Lonardi, Marine Cachanado, et al.
Pageof 20